These two high-flying biotechs are vying for the same market.The coronavirus vaccine market is only a few months old, but it is already worth well over $1 billion. And while companies such as Modernaand Pfizer are currently leaders in this space, others are working to throw their hats into the ring...

https://www.fool.com/investing/2021/05/15/ocugen-or-vaxart-which-will-take-investors-further/?source=iedfolrf0000001

#fool